VA Eastern Colorado Health Care System
Trial Pipeline
Supporting VETerans With Kidney Disease Through Food As Medicine
NCT07194733
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
NCT06375083
Activity Restrictions After Inguinal Hernia Repair
NCT05867134
University of Colorado - Restoring Efficient Sleep After TBI
NCT05683145
VISN 19 MIRECC Research Database
NCT01334476
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
NCT03729778
Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS
NCT01749007
Providing Mental Health Services to Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) Veterans
NCT01476618
Traumatic Brain Injury Among Homeless Veterans
NCT01120054
A Health & Wellness Intervention for Individuals With Traumatic Brain Injury (TBI)
NCT01334398
An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans
NCT01502436
Intensive Outpatient Treatment for Suicidal Veterans
NCT01334372
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Therapeutic Areas
What the Pipeline for VA Eastern Colorado Health Care System Shows
According to the ClinicalTrials.gov registry, VA Eastern Colorado Health Care System is linked to 39 US clinical trials across every stage of research activity. Of those, 32 studies are currently recruiting — about 82% of the sponsor's indexed portfolio — and 6 are already marked complete, representing roughly 15% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for VA Eastern Colorado Health Care System reports 0 late-stage studies (Phase 3 and Phase 4 combined) and 2 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for VA Eastern Colorado Health Care System is Traumatic Brain Injury with 4 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.